Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197138) titled 'IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Max-Planck-Institute of Psychiatry
Condition:
Depressive Disorder
Post-Acute COVID-19 Syndrome
Intervention:
Device: Intermittent theta-burst stimulation (iTBS) using PowerMAG 100 ppTMS
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 11, 2025
Target Sample Size: ...